# Solitary Fibrous Tumors of the Head and Neck: A Report of Two Cases and Review of the Literature

**Authors:** Jafar Hayat, Altaf A Alfadhly, Yasmeen Alshahoumi, Smiley-Annie George, Fareed Al Qusous, Maha Al-Gilani

PMC · DOI: 10.7759/cureus.101396 · Cureus · 2026-01-12

## TL;DR

This paper reports two rare cases of solitary fibrous tumors in the head and neck, emphasizing their diagnosis and treatment.

## Contribution

The study adds to the limited literature on SFTs in the cheek and floor of the mouth and highlights diagnostic markers like STAT6.

## Key findings

- Both cases showed SFT confirmation via histopathology and STAT6, CD34, BCL2, and CD99 immunostaining.
- Complete surgical excision was curative with no recurrence in short-term follow-up.
- SFTs should be considered in the differential diagnosis of soft tissue tumors in these rare locations.

## Abstract

Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms, particularly uncommon in the cheek and floor of the mouth. We report two such cases to emphasize diagnostic and management considerations. A retrospective review at a tertiary academic hospital included two female patients aged 40 and 49 years. Both underwent clinical evaluation, radiologic imaging, surgical excision, and histopathologic assessment with immunohistochemistry, including STAT6, CD34, BCL2, and CD99. Risk stratification was based on mitotic index and histological features. The first case involved a 40-year-old woman with a 3.5 × 2 × 1.5 cm lesion in the floor of the mouth. Histopathology confirmed SFT with STAT6, CD34, BCL2, and CD99 positivity; the mitotic rate was 1/10 HPF, consistent with low risk. The second case involved a 49-year-old woman with a 1.5 × 1.5 cm right cheek mass, also confirmed as SFT with a similar immunoprofile and negligible mitotic activity, indicating very low risk. Both patients underwent complete excision and recovered uneventfully, with no recurrence on a two-week follow-up. These cases illustrate that SFTs, though rare in the cheek and floor of the mouth, should be considered in the differential diagnosis of soft tissue tumors. Diagnosis depends on histopathology and immunohistochemistry, particularly STAT6. Complete excision is usually curative, but long-term surveillance remains essential.

## Linked entities

- **Proteins:** STAT6 (signal transducer and activator of transcription 6), CD34 (CD34 molecule), BCL2 (BCL2 apoptosis regulator), CD99 (CD99 molecule (Xg blood group))

## Full-text entities

- **Genes:** CD34 (CD34 molecule) [NCBI Gene 947], STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267] {aka HBA71, MIC2, MIC2X, MIC2Y, MSK5X}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}
- **Diseases:** Fibrous Tumors of the Head and Neck (MESH:D006258), mesenchymal neoplasms (MESH:D009369), SFTs (MESH:D054364), soft tissue tumors (MESH:D012983)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12900915/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12900915/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12900915/full.md

---
Source: https://tomesphere.com/paper/PMC12900915